2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy

M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.

Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.

“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.

While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.

“Long-term care pharmacies have experienced one of the steepest valuation declines in recent years as a result of COVID and home-based care,” Ulloa noted.

For more insight into the healthcare business market, follow the latest from M&A Healthcare Advisors here.

Follow us on social media for the latest updates in B2B!

Image

Latest

data center infrastructure
AI Is Forcing a Rethink of Data Center Infrastructure at Every Level
December 29, 2025

The data center industry is being redefined by AI’s demand for faster, denser, and more scalable infrastructure. According to McKinsey, average rack power densities have more than doubled in just two years. It went from approximately 8 kW to 17 kW, and is expected to hit 30 kW by 2027. Global data center power demand is projected…

Read More
Emergency department
How Predictive AI Is Helping Hospitals Anticipate Admissions and Optimize Emergency Department Throughput
December 24, 2025

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Read More
Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More
Benchmark
What Is It Like for You to Be Part of the Benchmark Products Teams Now
December 23, 2025

Being part of the Benchmark Products team today means working at the intersection of precision manufacturing and deeply human collaboration, especially in the high-stakes world of cleanroom and sterility assurance solutions. As the organization grows, employees describe a culture that still feels familial—one where clear communication, personal accountability, and genuine care for customers drive…

Read More